Reprogramming of the Trypanosoma brucei epigenome during human infection

Christopher S Carlson

Impact of primary tumor development stage on prognosis and outcome in B-ALL

Leukaemia

Pediatric oncology or childhood cancer

Venee Tubman

Pilot Neonatal Program for the Diagnosis and Surveillance of Sickle Cell Disease

Sarcoma Non-Hodgkin lymphoma Leukaemia Kidney, renal pelvis and ureter Hodgkin lymphoma Brain, nervous system

Xiaoyan Jiang

Targeting Drug-Insensitive CML Stem Cells with Combination Therapy of New ABL and PP2A Inhibitors

Leukaemia

Tracy L Mcgaha

The role of marginal zone macrophages and immuno-metabolism in tumor-driven MDSC development

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Investigator from French Institute of Health and Medical Research (INSERM)

Integrated study of the role of B-cell receptor signaling in the development of Follicular Lymphoma

Non-Hodgkin lymphoma Hodgkin lymphoma

Catherine Ju-Ying Wu

(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL

Leukaemia

Christophe P Nicot

HTLV-I Tax induces DNA Breaks and Inhibits HR Repair through Activation of NF-kB

Leukaemia

Hematology and hematologic malignancies Pathology

Richard E Champlin

The Therapy of Chronic Myeloid Leukemia (CML)

Leukaemia

Hematology and hematologic malignancies Pathology

Targeting BCL6 in Tyrosine Kinase-Driven Leukemia

Leukaemia

Hematology and hematologic malignancies Pathology